Results 201 to 210 of about 493,471 (293)

Energy Balancing of Electrochemical Alternatives to the Solvay Process

Chemie Ingenieur Technik, EarlyView.
To overcome the CaCl2 and CO2 emissions custom to the conventional Solvay process in soda ash production, electrochemically based alternatives were investigated. In particular, the mass‐ and energy balances for chlor‐alkali electrolysis and bipolar electrodialysis‐based processes are discussed comprehensively in the presented work.
Tom Wenzel, Holger Kryk, Stefan Fogel, Sebastian Felix Reinecke   +3 more
wiley   +1 more source

Return to work - estimated socioeconomic impact of spontaneous intracranial hypotension and effects of neurosurgical treatment. [PDF]

Front Neurol
Omer M, Wolf K, Overstijns M, El Rahal A, Lützen N, Urbach H, Zander C, Krismer L, Klingler JH, Hohenhaus M, Shah M, Beck J, Volz F.   +12 more
europepmc   +1 more source

Performance comparison of pressure swing adsorption and amine‐based absorption for synthesis gas purification

The Canadian Journal of Chemical Engineering, EarlyView.
Comparison of PSA and amine‐based absorption for syngas purification shows that PSA offers lower energy intensity, global warming potential, and minimum selling price, making it a more sustainable option. However, absorption achieves higher syngas purity. A GREENSCOPE‐based multi‐criteria assessment guides optimal process selection.
Magno Fonseca Santos, Antonio Esio Bresciani, Rita Maria Brito Alves   +2 more
wiley   +1 more source

EO-based long term cropland and paddy monitoring with the farm action toolkit (FAcT): strengthening policy support in Bhutan. [PDF]

Discov Agric
Phalke AR, Cox SE, Limaye AS, Dorji R, Phuntsho L, Wangchen T, Rai M, Tshering C, Anderson ER, Nakalembe CL, Mayer TJ, Griffin R.   +11 more
europepmc   +1 more source

Carbon Footprint of Antibody‐Based Drugs and Biologics Using Hybrid Life Cycle Assessment

Clinical Pharmacology &Therapeutics, EarlyView.
Life cycle assessment of monoclonal antibodies. Biological engineering has emerged since the 1980s as one of the most efficient technologies to develop new medicines. The monoclonal antibody platform is the most widely used, representing about 15–20% of drug sales.
Sébastien Taillemite, Martin Fenelon, Marc Scherlinger, Max Piffoux   +3 more
wiley   +1 more source

A causal framework for evaluating drivers of policy effect heterogeneity using difference-in-differences. [PDF]

Health Serv Outcomes Res Methodol
Hettinger G, Lee Y, Mitra N.
europepmc   +1 more source

Prediction of Acute Liver Injury Trajectory in Patients Following Acetaminophen Overdose: A Multibiomarker Machine Learning Proof‐of‐Concept Study

Clinical Pharmacology &Therapeutics, EarlyView.
Clinical translation of novel therapies can be hindered by heterogeneity‐driven sample size inflation in late‐stage trials. In acetaminophen‐induced liver injury (APAP DILI), many patients recover spontaneously, diluting investigational drug efficacy signals.
Chris Humphries, Alastair M. Kilpatrick, Kathleen M. Scullion, Rhona Aird, Lorraine Bruce, Maria Elena Candela, Tak Yung Man, Stuart J. Forbes, James W. Dear   +8 more
wiley   +1 more source

System Preparedness for Rising Kidney Replacement Therapy Demand: Late-Stage CKD Drives Costs, Healthcare Resource Utilisation and Environmental Impact in Switzerland. [PDF]

Adv Ther
Campbell-James T, Buff S, Nanchen G, Hall A, Rosemann T, Nicholson L, Priest S, Zara A, Hubbert L, Vecchio Rodriguez C, Wharton G, Pruijm M.   +11 more
europepmc   +1 more source

Exploring the Interrelationships Among Supply Chain Emissions, Financial Performance, Market Value, and Board Sustainability: An Exploration of the European Landscape

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT National and supranational institutions are establishing emission trading systems and control schemes in an attempt to manage stakeholders' willingness to engage with regulatory systems and reduce greenhouse gas emissions (GHG). Nonetheless, despite the national and supranational focus on carbon neutrality, little research has been centered ...
Daniele Giordino, Martina Panero, Nourah O. Alshaghdali, Judith Petra Koltai   +3 more
wiley   +1 more source

No fault vaccine injury compensation after COVID-19: A systematic literature review and proposed typology. [PDF]

Hum Vaccin Immunother
Halabi S, Arora N, Durran A, Qian Q, Ummer S, Ginsbach K, Aneja K.   +6 more
europepmc   +1 more source